A Pilot Study of the Use of Dual-Energy X-ray Absorptiometry (DXA) in Scoliosis

Status: Recruiting
Location: See location...
Intervention Type: Radiation
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a pilot study to look at image quality of iDXA AP supine spinal images to see if the investigators can accurately measure the size of the curve from iDXA images and to see how patients with scoliosis feel about iDXA imaging compared to normal x-rays. With normal x-rays being taken standing (or sitting if patients are in a wheelchair), it is important that the investigators understand how the lying down images compare to the standing images. Where there may be some clinical benefit, images will be taken standing (normal x-rays) and lying down (iDXA images). The investigators will see if the addition of iDXA images can help in brace design and brace monitoring.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 4
Maximum Age: 16
Healthy Volunteers: f
View:

• Patients with Adolescent Idiopathic Scoliosis (AIS, aged 10-16 years) or Juvenile Idiopathic Scoliosis (JIS, aged 4-9 years) having an x-ray to look for curve progression OR to guide design of a new brace.

• Patients with quadriplegic Cerebral Palsy (CP) having an x-ray to look for curve progression. Within the age range for inclusion for patients with CP, the recruiting clinician will make a clinical judgement on whether the patient is able to lie still long enough to undertake the iDXA, before inviting the patient to take part.

Locations
Other Locations
United Kingdom
Sheffield Children's NHS Foundation Trust
RECRUITING
Sheffield
Time Frame
Start Date: 2024-05-08
Estimated Completion Date: 2025-05-31
Participants
Target number of participants: 20
Treatments
Other: ADDITIONAL DEXA SCAN
There is only 1 arm on this trial, if a participant agrees to take part they will have additional DEXA radiograph.
Related Therapeutic Areas
Sponsors
Leads: Sheffield Children's NHS Foundation Trust
Collaborators: University of Sheffield

This content was sourced from clinicaltrials.gov